Myosin V is an unconventional myosin thought to move processively along actin filaments. To have hard evidence for the high processivity, we sought to observe directly the movement by individual native chick brain myosin V (BMV) molecules with fluorescent calmodulin. Single BMV molecules did exhibit highly processive movement along actin filaments fixed to a coverslip. BMV continued to move up to the barbed end of its actin track, and did not readily detach from action. The barbed end, therefore, got brighter with time, because of a constant stream of BMV traffic. The maximum speed of the processive movement was 1 m/s, and the maximum actinactivated ATPase rate was 2.4 s ؊1 . These values apparently imply that BMV travels a great distance, 400 nm, per an ATPase cycle. © 2000 Academic Press Key Words: motor protein; sliding movement; processivity; ATPase; actin; myosin.
The transport of vesicles and organelles to specific locations is a fundamental process in cells. This process is performed mainly by actin-based and microtubulebased protein motors. Of the unconventional myosin families the class V myosins have been shown to transport synaptic and endoplasmic reticulum vesicles in neurons (1) (2) (3) , pigment granules in melanocytes (4, 5) , and the vacuole in yeast (6, 7) . Myosin V consists of two N-terminal heads containing the actin-binding and ATP hydrolysis sites, two extended neck domains each of which contains six IQ motifs, and a tail domain consisting of a coiled-coil region attached to a C-terminal globular region (8 -10) . The IQ motifs form binding sites for calmodulin (CaM) and related light chains (9 -11) . Unlike myosin II, the tail does not selfassociate, and therefore myosin V does not form filaments (10, 12) . The C-terminal globular region is believed to associate with cargo to be carried by myosin V. The cycling rate of the actin-activated ATPase is limited by the ADP-release step, which allows myosin V to spend a large part of the cycle time strongly bound to actin (13, 14) . This kinetic nature has not been found yet in the other myosin families.
Based on the cellular functions and the ATPase kinetics, myosin V has been inferred to be a processive motor like the microtubule-based motors, kinesin (15, 16) and dynein (17) , that is, a single myosin V molecule may be able to travel long distances along its actin track, repeating its ATPase cycles. The processivity is more directly suggested by a recent observation that actin filaments moved continuously over surfaces coated with BMV (myosin V purified from chick brain) at low densities, and swiveled about a single contact point as they moved (12) . Moreover, it was shown in an optical trapping assay that a single molecule of BMV pulled an actin filament successively for three-to-five, not many, steps before being stalled by the optical trapping force (12) . In the present study we directly observed movement by individual BMV molecules on fixed actin tracks, and found that BMV travels over a distance of several micrometers without detaching from actin, that is, BMV makes many steps in succession.
MATERIALS AND METHODS
Proteins. BMV was prepared as described (18) , stored at 0°C, and used within a week. Actin was prepared from rabbit skeletal muscle, and purified as described (19) . Bovine brain CaM and bovine serum albumin (BSA; fraction V) was obtained from Sigma (USA). Streptavidine was obtained from Life Technologies (USA).
Cy3-labeling of calmodulin. After dialyzing against Buffer A (0.3 M KCl, 50 mM boric acid (pH 8.5), 0.1 mM CaCl 2 ), bovine brain CaM (15 M) was mixed with 30 M Cy3-Osu (Amersham Pharmacia Biotech, UK) and incubated for 1 h at 25°C. After adding 5 mM dithiothreithol (DTT) to stop the reaction, it was exhaustively dialyzed against Buffer B (25 mM KCl, 20 mM imidazole (pH 7.6), 2 mM MgCl 2 , 1 mM EGTA) plus 2 mM ␤-mercaptoethanol (␤-ME). The concentration of Cy3 in the Cy3-CaM was estimated by the absorbance at 550 nm and the molar extinction coefficient, 1.5 ϫ 10
Preparation of Cy3-BMV. BMV (150 nM) was mixed with Cy3-CaM (1.5 M) in Buffer B plus 5 mM DTT, and incubated for 2 min at 25°C. After adding CaCl 2 (final 1.01 mM), the mixture was incubated for 5 min at 25°C, followed by the addition of EGTA (final 4 mM). To remove free Cy3-CaM, the sample was mixed with F-actin (final 1 M), and centrifuged (148,000g, 1 h). The pellet was dissolved in Buffer C (250 mM KCl, 2 mM MgCl 2 , 1 mM EGTA, 20 mM imidazole (pH 7.6), 5 mM DTT, 2 mM ATP). The acto-Cy3-BMV was applied to a Q-Sepharose (Amersham Pharmacia Biotech, Sweden) column (volume, 400 l). F-actin was removed from the sample by washing the column with 20 ml of Buffer C. After washing the column with 20 ml of Buffer C without ATP, Cy3-BMV was eluted out with a linear gradient 0.25-1 M KCl with 20 mM imidazole (pH 7.6), 2 mM MgCl 2 , 1 mM EGTA and 5 mM DTT (total 30 ml), and dialyzed against Buffer B plus 2 mM ␤-ME.
In vitro actin-filament sliding assay. The assay was according to Toyoshima et al. (20) , with a slight modification (cover slips for flow cells were treated with 0.2%, instead of 0.1%, nitrocellulose isopentyl acetate solution for 1 min). F-actin was labeled with rhodaminegreen phalloidine (RGP). BMV or Cy3-BMV (100 nM, 20 l) was applied to the flow cell (volume 10 -20 l), and incubated for 2 min. The cell was washed with 200 l of Buffer B. Then, 50 l of BSA (1 mg/ml in Buffer B) was put into the cell, which was incubated for 2 min and was washed with Buffer B. RGP-labeled F-actin (8 nM, 100 l) was applied to the cell and incubated for 2 min. Finally, the buffer solution was replaced with motility buffer containing 20 mM imidazole (pH 7.6), 2 mM MgCl 2 , 1 mM EGTA, 2 mM ␤-ME, 2 mM ATP, various concentrations of KCl, and an oxygen-scavenging system (0.2 mg/ml glucose oxidase, 0.36 mg/ml catalase and 4.5 mg/ml glucose). Sliding movement of actin filaments was observed at 25°C using an SIT video camera (C2741-08, Hamamatsu Photonics) connected to an unmodified microscope (Olympus IX70; equipped with an oilimmersion objective, 100s, NA 1.35) with epifluorescence excitation with a high-pressure mercury lamp and a filter set (U-MNIBA; Olympus, Japan). The images were recorded with a Hi8 video cassette recorder (EVO-9659, Sony, Japan). The recorded images were digitized with an image processor (Excel, Nippon Avionics, Japan) and the two-dimensional coordinates of the rear end of each actin filament were chased frame by frame. Length of a track connecting these coordinates during a given period of time was calculated and averaged over more than fifty actin filaments. The sliding velocity was obtained by dividing the average value of the lengths of tracks by the given period of time.
In vitro BMV movement assay. G-actin (10 M) was mixed with 50 M biotin-maleimide (Dojindo Laboratories, Japan) in a solution containing 20 mM TES-HCl (pH 7.0), 0.2 mM CaCl 2 , 0.1 mM NaN 3 , 0.2 mM ATP, and incubated for 1 h at 25°C. After adding 5 mM DTT to stop the reaction, the biotinylated G-actin was dialyzed against the same buffer solution. The concentration of biotin incorporated into G-actin was measured as described (19) . One-to-one stoichiometric incorporation was achieved. The biotinylated G-actin was copolymerized with nonlabeled G-actin (the molar ratio, 1:200) in Buffer B. This ratio seemed important for observing processive movement by Cy3-BMV. The resulting F-actin was labeled with RGP or phalloidine, and then fixed onto a coverslip as follows. First, BSA was biotinylated with biotin-(AC 5 ) 2 -Osu (Dojindo Laboratories, Japan) in a BSA/biotin molar ratio of 1:20 in 0.1 M boric acid, pH 8.8 for 90 min at 25°C, and dialyzed against Buffer B. The sample contained 2 biotins per BSA. The biotin-BSA (10 M, 20 l) was applied to a flow cell (volume 10 l) made of two nitrocellulose-coated coverslips. The cell was incubated for 2 min, and washed with 300 l of Buffer B. Streptavidin (0.5 mg/ml, 10 l) dissolved in Buffer B was applied to the cell, and incubated for 3 min. Unattached Streptavidin was washed out with 600 l of Buffer B. The partially biotinylated F-actin (1 M, 20 l) was applied to the cell, and incubated for 2 min. Unattached F-actin was washed out with 200 l of Buffer B. Finally, Cy3-BMV (1 nM) in 100 l of motility buffers was applied to the cell. Motility buffers are the same as those used for the actin-filament sliding assay. Fluorescence image of Cy3-BMV was observed using an objective-type total internal reflection fluorescence (OTIRF) video microscope, and recorded with a digital video cassette recorder (DSR-20, Sony, Japan). The two-dimensional coordinates of each Cy3-BMV were chased frame by frame. Length of a track connecting these coordinates during a given period of time was calculated and averaged over more than 100 Cy3-BMV molecules. The sliding velocity was obtained by dividing the average value of the lengths of tracks by the given period of time.
Microscopy. The OTIRF microscope was constructed as described (21) , using an epifluorescence microscope (IX50; Olympus) equipped with an oil-immersion objective lens (PlanApo 100ϫ, NA 1.4) and a relay lens (PE5, 5ϫ; Olympus) connected to an SIT video camera (C2400-08S; Hamamatsu Photonics). The excitation light source is a diode green laser (model 4601-050, 532 nm, 50 mW; Uniphase) attenuated by two 20% neutral density filters.
ATPase assay. Actin-activated BMV and Cy3-BMV ATPase activities were measured at three different [KCl] with nine different actin concentrations. The buffer solution contained 2 mM ATP, 20 mM imidazole (pH 7.6), 2 mM MgCl 2 , 1 mM EGTA, and KCl (25, 100, or 200 mM). The concentration of BMV or Cy3-BMV was 30 -60 nM. Amounts of phosphate liberated at 25°C were quantified by the method of Fiske and Subbarow (22) . The ATPase activities were determined by analyzing the amounts of phosphate liberated at seven time points by the least-squares criterion.
F-actin cosedimentation assays. BMV (150 nM) or Cy3-BMV (150 nM) was mixed with 40 M F-actin at 25°C in 2 mM ATP, 20 mM imidazole (pH 7.6), 2 mM MgCl 2 , 1 mM EGTA, 2 mM ␤-ME and three different [KCl] (25 mM, 80 mM, or 150 mM). The samples (200 l) were then immediately centrifuged (148,000g, 45 min, 25°C). The supernatants were carefully aspirated and mixed with 50 l SDS sample buffer. The pellets were resuspended in the buffer solution (200 l) plus 50 l SDS sample buffer. Pellet and supernatant were run on SDS polyacrylamide gels and silver-stained. As a control, it was confirmed that BMV or Cy3-BMV alone was not sedimented, irrespective of the presence of ATP.
FIG. 1. Distributions of spot intensities (arbitrary units) for (a)
Cy3-CaM and (b) Cy3-BMV. The spot intensities were obtained by integrating the intensity over a square (13 ϫ 13 pixels) enclosing the spot and subtracting a background integrated over the same square after complete photobleaching of Cy3.
RESULTS AND DISCUSSION
To visualize BMV under the OTIRF microscope we first attempted to label BMV directly with amino-reactive or SH-reactive fluorophores. The labeled BMV, however, did not support in vitro actin-filament sliding. So, next, we exploited the property of BMV that calmodulin (CaM) attached to the neck region can dissociate partially in the presence of a micromolar order of Ca 2ϩ , and the resulting vacant CaM-binding sites can be refilled when [Ca 2ϩ ] is returned to a much lower level in the presence of excess amounts of free CaM (10, 11). As the exogenous CaM, we used bovine CaM labeled with a fluorophore, Cy3 (Cy3/ CaM ϭ 1.85). In this way a part of the endogenous CaM was successfully replaced with the fluorescent CaM. This sample of BMV contained 4.2 Cy3/BMV, indicating that 2.2 CaMs were replaced on the average. This Cy3-BMV supported in vitro motility of actin filaments indistinguishably from that produced by non-labeled BMV (the maximum velocity is 0.55 m/s). OTIRF video microscopy was employed to observe Cy3-BMV molecules attached to a coverslip. We saw light spots on the monitor. To examine whether these spots represent individual Cy3-BMV molecules, distribution of spot intensities of the Cy3-BMV sample (I M ) was compared with that of Cy3-CaM (I C ) (Fig. 1) . The ratio of the mean values, i.e., ͗I M ͘/͗I C ͘, was 2.1. This value was quite similar to the average number of substituted CaM measured in solution, indicating that Cy3-BMV is not oligomerized. Electron microscopic observation of Cy3-BMV also supported this conclusion (data not shown).
We constructed an in vitro BMV motility assay system by attaching partly (0.5%) biotinylated actin filaments onto a streptavidine-coated coverslip. After attaching to an actin filament, Cy3-BMV moved continuously and smoothly on its actin track (Fig. 2a) . At [KCl] lower than 100 mM, Cy3-BMV molecules often traveled up to the barbed ends of actin filaments. After reaching the barbed ends, Cy3-BMV did not readily detach from actin. The barbed ends were, therefore, getting brighter with time because of a constant stream of Cy3-BMV traffic (Fig. 2b and 2c) . At [KCl] higher than about 150 mM, Cy3-BMV often detached from actin before reaching the barbed end of its actin track. The distance that Cy3-BMV traveled seemed to fit single exponential statistics (Fig. 3a-3d) , and decreased with increasing [KCl] (Fig. 3e) . The processive movement was still visible even at 400 mM KCl, although the mean travel distance was small (about 660 nm). The rate of movement was 0.54 m/s at 25 mM KCl, increased moderately with increasing [KCl], and reached a plateau (1 m/s) at about 150 mM KCl (Fig. 3f) . This behavior is different from that of kinesin. The rate of processive movement of kinesin is independent of ionic strength (15) .
The actin-activated BMV and Cy3-BMV ATPase activities were measured in 2 mM ATP and three different [KCl] Ϫ1 /BMV), 12 times larger than the value measured here. If so, it is understandable that large ensembles of BMV molecules produced actin-filament sliding at a rate half that with movement of single BMV molecules. We tested this hypothesis by cosedimentation assays for BMV and Cy3-BMV binding to F-actin in 2 mM ATP. It came out that this hypothesis did not fit, because a large fraction of BMV and Cy3-BMV were cosedimented with F-actin, even at 150 mM KCl (Fig.  4) . This cosedimentation does not mean that our BMV sample contains a large fraction of denatured BMV, but that BMV is mainly in the strong-binding states during the ATPase cycle (13, 14) . If denatured, it must produce resistive drag force against actin-filament sliding, as has been observed with skeletal heavy meromy- osin, wherein only 15-20% denatured fraction of heavy meromyosin is sufficient to stop actin-filament sliding. The ATPase activity as high as 14 s Ϫ1 /head has been reported for native BMV in the presence of a micromolar order of Ca 2ϩ (23) and for truncated, single-headed myosin V constructs with one or two single light chains in the absence of Ca 2ϩ (13, 25) . The high ATPase activities are, however, ascribed to the absence of an inhibitory effect of CaM on the acto-BMV ATPase reaction (23) . Without the inhibitory effect of CaM, BMV does not support in vitro motility of actin filaments (10) .
Here, we provided hard evidence that BMV is a highly processive motor that can travel over a distance of many micrometers without detaching from actin. However, it raised a new riddle about the mechanochemical coupling of this protein motor, which should be solved in the future.
